Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PERFLUTREN Cause Chronic obstructive pulmonary disease? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Chronic obstructive pulmonary disease have been filed in association with PERFLUTREN (DEFINITY RT). This represents 0.1% of all adverse event reports for PERFLUTREN.

5
Reports of Chronic obstructive pulmonary disease with PERFLUTREN
0.1%
of all PERFLUTREN reports
1
Deaths
3
Hospitalizations

How Dangerous Is Chronic obstructive pulmonary disease From PERFLUTREN?

Of the 5 reports, 1 (20.0%) resulted in death, 3 (60.0%) required hospitalization.

Is Chronic obstructive pulmonary disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PERFLUTREN. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does PERFLUTREN Cause?

Back pain (1,350) Muscle spasms (604) Dyspnoea (551) Pain in extremity (397) Flushing (263) Chest pain (254) Neck pain (249) Headache (248) Dizziness (232) Nausea (177)

What Other Drugs Cause Chronic obstructive pulmonary disease?

ALBUTEROL (2,916) TIOTROPIUM (2,895) BUDESONIDE\FORMOTEROL (2,279) FLUTICASONE\SALMETEROL (1,904) ADALIMUMAB (1,712) PREDNISONE (1,237) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145) MEPOLIZUMAB (1,107) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967) DUPILUMAB (907)

Which PERFLUTREN Alternatives Have Lower Chronic obstructive pulmonary disease Risk?

PERFLUTREN vs PERICIAZINE PERFLUTREN vs PERINDOPRIL PERFLUTREN vs PERINDOPRIL ARGININE PERFLUTREN vs PERINDOPRIL ERBUMINE PERFLUTREN vs PERJETA

Related Pages

PERFLUTREN Full Profile All Chronic obstructive pulmonary disease Reports All Drugs Causing Chronic obstructive pulmonary disease PERFLUTREN Demographics